RU2020105484A3 - - Google Patents

Download PDF

Info

Publication number
RU2020105484A3
RU2020105484A3 RU2020105484A RU2020105484A RU2020105484A3 RU 2020105484 A3 RU2020105484 A3 RU 2020105484A3 RU 2020105484 A RU2020105484 A RU 2020105484A RU 2020105484 A RU2020105484 A RU 2020105484A RU 2020105484 A3 RU2020105484 A3 RU 2020105484A3
Authority
RU
Russia
Application number
RU2020105484A
Other versions
RU2020105484A (ru
RU2792210C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020105484A publication Critical patent/RU2020105484A/ru
Publication of RU2020105484A3 publication Critical patent/RU2020105484A3/ru
Application granted granted Critical
Publication of RU2792210C2 publication Critical patent/RU2792210C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6831Fungal toxins, e.g. alpha sarcine, mitogillin, zinniol or restrictocin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2020105484A 2017-08-07 2018-08-06 Новый способ синтеза аманитинов RU2792210C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17185182.7 2017-08-07
EP17185182 2017-08-07
PCT/EP2018/071268 WO2019030173A1 (en) 2017-08-07 2018-08-06 NOVEL METHOD FOR SYNTHESIZING AMANITINES

Publications (3)

Publication Number Publication Date
RU2020105484A RU2020105484A (ru) 2021-08-05
RU2020105484A3 true RU2020105484A3 (ru) 2021-09-13
RU2792210C2 RU2792210C2 (ru) 2023-03-20

Family

ID=

Also Published As

Publication number Publication date
AU2018314668B2 (en) 2022-06-02
CA3066867A1 (en) 2019-02-14
RU2020105484A (ru) 2021-08-05
JP2020529452A (ja) 2020-10-08
ZA201908158B (en) 2022-12-21
WO2019030173A1 (en) 2019-02-14
CL2020000304A1 (es) 2020-08-07
KR102674750B1 (ko) 2024-06-13
CN111051310A (zh) 2020-04-21
US20210130412A1 (en) 2021-05-06
CO2020001259A2 (es) 2020-02-18
US10961277B2 (en) 2021-03-30
JP7165720B2 (ja) 2022-11-04
SG11201912224PA (en) 2020-01-30
NZ760113A (en) 2024-07-05
US20200181200A1 (en) 2020-06-11
CN111051310B (zh) 2022-11-08
MX2020001472A (es) 2020-10-19
EP3665173A1 (en) 2020-06-17
US11702451B2 (en) 2023-07-18
BR112020001345A2 (pt) 2020-08-11
KR20200037207A (ko) 2020-04-08
AU2018314668A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
BR112020006084A8 (ru)
RU2020105484A3 (ru)
BR202018014992U2 (ru)
BR202017025154U2 (ru)
BR102017023327A2 (ru)
BR202017021228U2 (ru)
BR202017020981U2 (ru)
BE2017C035I2 (ru)
BR202017017068U2 (ru)
BR202017016984U2 (ru)
BR202017016924U2 (ru)
BR102017015495A2 (ru)
BR102017015250A2 (ru)
BR102017014430A2 (ru)
BR202017012548U2 (ru)
BR202017011220U2 (ru)
BR202017010814U2 (ru)
BR102017003115A2 (ru)
CN303991388S (ru)
CN303892651S8 (ru)
CN303997226S (ru)
CN303996895S (ru)
CN303993402S (ru)
CN303991389S (ru)
CN303998444S (ru)